Biogen Idec gains commercial rights of Tysabri from Elan

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: 9 years ago
Contact:

Biogen Idec gains commercial rights of Tysabri from Elan

Post by MSUK » 5 years ago

Biogen Idec gains commercial rights of Tysabri from Elan Corporation

Biogen Idec has completed its purchase of Elan Corporation’s interest in Tysabri (natalizumab) and has gained full strategic, commercial and decision-making rights of Tysabri. The transaction was originally announced on February 6, 2013....................Read More - http://www.ms-uk.org/index.cfm/tysabri
MS-UK - http://www.ms-uk.org/

User avatar
HarryZ
Family Elder
Posts: 2570
Joined: 14 years ago
Location: London, ON, Canada
Contact:

Re: Biogen Idec gains commercial rights of Tysabri from Elan

Post by HarryZ » 5 years ago

squiffy2 wrote:Biogen Idec gains commercial rights of Tysabri from Elan Corporation

Biogen Idec has completed its purchase of Elan Corporation’s interest in Tysabri (natalizumab) and has gained full strategic, commercial and decision-making rights of Tysabri. The transaction was originally announced on February 6, 2013....................Read More - http://www.ms-uk.org/index.cfm/tysabri
Makes you wonder if Elan knows something about Tysabri that we don't and got out after making as much money as they could.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post